Essential role of vaccines in brucellosis control and eradication programs for livestock

References

• Paulsen IT, Seshadri R, Nelson KE et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts. Proc. Natl Acad. Sci. USA 99, 13148–13153 (2002).
   PubMed Web of Science ®Google Scholar
• Halling SM, Peterson-Burch BD, Bricker BJ et al. Completion of the genome sequence of Brucella abortus and comparison to the highly similar genomes of Brucella melitensis and Brucella suis. J. Bacteriol. 187, 2715–2726 (2005).
   PubMed Web of Science ®Google Scholar
• Verger JM, Grimont F, Grimont PAD, Grayon M. Brucella, a monospecific genus as shown by deoxyribonucleic acid hybridization. Int. J. Syst. Bacteriol. 35, 292–295 (1985).
   Google Scholar
• Lucero NE, Jacob NO, Ayala SM, Escobar GI, Tuccillio G, Jacques I. Diagnosis of human brucellosis caused by Brucella canis. J. Med. Microbiol. 54, 457–461 (2005).
   PubMed Web of Science ®Google Scholar
• Ewalt DR, Payeur JB, Rhyan JC, Geer PL. Brucella suis biovar 1 in naturally infected cattle: a bacteriological, serological and histological study. J. Vet. Diagn. Invest. 9, 417–420 (1997).
   PubMedGoogle Scholar
• Banai M. Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Vet. Microbiol. 90, 497–519 (2002).
   PubMed Web of Science ®Google Scholar
• Minas A, Minas M, Stournara A, Tselepidis S. The ‘effects’ of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev. Vet. Med. 64, 41–47 (2004).
   PubMed Web of Science ®Google Scholar
• Blasco JM. Brucella ovis. In: Animal Brucellosis. K Nielsen, JR Duncan (Eds) CRC Press, Boston, MA. 351–378 (1990).
   Google Scholar
• Nicoleti P, Wilward FW. Protection by oral administration of Brucella abortus strain 19 against an oral challenge exposure with a pathogenic strain of Brucella. Am. J. Vet. Res. 44, 1641–1643 (1983).
   PubMedGoogle Scholar
• Deng P-H, Pan H-Y, Ye C-Y. Brucellosis control in China. Proceedings of the United States Animal Health Association. 94, 106–109 (1990).
   Google Scholar
• Mustafa AA, Abusowa M. Field oriented trials of the Brucella suis strain 2 vaccine on sheep and goats in Libya. Vet. Res. 24, 422–429 (1993).
   PubMedGoogle Scholar
• Nicoletti P, Winter AJ. The immune response to Brucella abortus – the cell-mediated response to infections. In: Animal Brucellosis. K Nielsen, JR Duncan (Eds.) CRC Press, Boston, MA. 83–96 (1990).
   Google Scholar
• Huang L-Y, Krieg AM, Eller N, Scott DE. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria. Infect. Immun. 67, 6257–6263 (1999)
   PubMedGoogle Scholar
• Manthei CA. Summary of controlled research with strain 19. Proceedings of the US Livestock Sanitary Association. 63, 91–97 (1959).
   Google Scholar
• Alton GG, Jones LM, Garcia-Carillo C,Trenchi A. Brucella abortus 45/20 vaccines in goats: immunity experiment. Am. J. Vet. Res. 33, 1747–1751 (1972).
   PubMedGoogle Scholar
• Confer AW, Hall SM, Faulkner CB et al. Effects of challenge dose on the clinical and immune responses of cattle vaccinated with reduced doses of Brucella abortus strain 19. Vet. Microbiol. 10, 561–575 (1985).
   PubMedGoogle Scholar
• Mitchell CA, Moore T. Brucella abortus (Strain 19) and calfhood vaccination. Can. J. Comp. Med. 4, 1–16 (1940).
   Google Scholar
• Vemulapalli, R, He Y, Sriranganathan N, Boyle SM, Schurig GG. Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines. Vet. Microbiol. 90, 521–532 (2002).
   PubMedGoogle Scholar
• Onate AA, Cespedes S, Cabrera A et al. A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB/c mice. Infect. Immun. 71, 4857–4862 (2003).
   PubMed Web of Science ®Google Scholar
• Ray WC, Brown RR, Stringfellow DA, Schnurrenberger PR, Scanlan CM, Swann AI. Bovine brucellosis: an investigation of latency in progeny of culture-positive cows. J. Am. Vet. Med. Assoc. 192, 182–186 (1988).
   PubMed Web of Science ®Google Scholar
• Wilesmith JW. The persistence of Brucella abortus infection in calves: A retrospective study of heavily infected herds. Vet. Record 103, 149–153 (1978).
   PubMed Web of Science ®Google Scholar
• Lapraik RD, Moffat R. Latent bovine brucellosis Vet. Record 111, 578–579 (1982).
   PubMed Web of Science ®Google Scholar
• Crawford RP. Huber JD, Sanders RB. Brucellosis in heifers weaned from seropositive dams. J. Am. Vet. Med. Assoc. 189, 547–549 (1986).
   PubMed Web of Science ®Google Scholar
• Kolar J. FAO/WHO/OIE Round Table on the use of Rev.1 Vaccine in Small Ruminants and Cattle. Some experience from brucellosis control with Rev.1 vaccine in a heavily infected country–Mongolia. In: Garin-Bastuji B, Benkirane A (Eds). CNEVA, Alfort, 77–81(1995).
   Google Scholar
• McEwen AD, Samuel J. McA. Brucella abortus: heat stable protective antigen revealed by adjuvant and present in a ‘rough’ variant, Strain 45/20: immunisation experiments on guinea-pigs. Vet. Record 67, 546–548 (1955).
   Google Scholar
• McEwen AD, Roberts RS. Bovine contagious abortion. The use of guinea-pigs in immunization studies. J. Comp. Pathol. Ther. 49, 97–117 (1936).
   Google Scholar
• Adams LG. Development of live brucella vaccines. In: Advances in Brucellosis Research. L.G. Adams (Ed.) 250–276 (1990).
   Google Scholar
• McEwen AD. The virulence of B. abortus for laboratory animals and pregnant cattle. Vet. Record 41, 97–106 (1940).
   Google Scholar
• Sutherland SS, Robertson AG, LeCras DV, Robertson GM, Johnston JM, Evans RJ. The effect of challenge with virulent Brucella abortus on beef cattle vaccinated as calves or adults with either Brucella abortus strain 19 or 45/20. Aust. Vet. J. 57, 470–472 (1981).
   PubMedGoogle Scholar
• Woodward LF, Jasman RL. Comparative efficacy of an experimental S45/20 bacterin and a reduced dose of strain 19 vaccine against bovine brucellosis. Am. J. Vet. Res. 44, 907–910(1983).
   PubMedGoogle Scholar
• Graves RR. Story of John M. Buck’s and Matilda’s contribution to the cattle industry. J. Am. Vet. Med. Assoc. 102, 193–195 (1989).
   Google Scholar
• Meyer ME, Nelson CJ. Persistence of Brucella abortus strain 19 infection in immunized cattle. Proceedings of the United States Animal Health Association 159–165 (1969).
   Google Scholar
• Jones LM, Berman DT. The role of living vaccines in prophylaxis. Dev. Biol. Stand. 31, 328–334 (1976).
   PubMedGoogle Scholar
• Thomas EL, Bracewell CD, Corbel MJ. Characterisation of Brucella abortus strain 19 cultures isolated from vaccinated cattle. Vet. Record 108, 90–93 (1981).
   PubMedGoogle Scholar
• Adams LG, Mia SM, Field evaluation of ‘D–Tec Brucella A’, a monoclonal antibody-based competitive enzyme-linked immunosorbent assay (cELISA) for serodiagnosis of brucellosis in cattle. Proceedings of the United States Animal Health Association 95, 92–112 (1991).
   Google Scholar
• Díaz R, Garatea P, Jones LM, Moriyón I. Radial immunodifussion test with a Brucella polysaccharide antigen for differentiating infected from vaccinated cattle. J. Clin. Microb. 10, 37–41 (1979).
   PubMed Web of Science ®Google Scholar
• Davies G, Cocks E, Hebert N. Brucella abortus (Strain 19) vaccine: (a) Determination of the minimum protective dose in cattle; (b) The effect of vaccinating calves previously inoculated with antiBrucella abortus serum. J. Biol. Standard. 8, 165–175 (1980).
   PubMedGoogle Scholar
• Deyoe BL, Dorsey TA, Meredith KB, Garrett L. Effect of reduced dosages of Brucella abortus strain 19 in cattle vaccinated as yearlings. Proceedings of the United States Animal Health Association.83, 92–104 (1979).
   Google Scholar
• Wright AE. Report of the co-operative bovine brucellosis work in the United States. Proceedings of the United States Livestock Sanitary Association 47, 149–154 (1942).
   Google Scholar
• Good, ER, Manthei CA, Amerault TE. Further studies on duration of immunity to brucellosis induced in calf-vaccinated cattle with strain 19 vaccine. Proceedings of the Livestock Sanitary Association 89–96 (1956).
   Google Scholar
• Manthei CA. Application of research to bovine brucellosis control and eradication programs. J. Dairy Sci. 51, 1115–1120 (1968).
   PubMedGoogle Scholar
• Nicoletti P. A preliminary report on the efficacy of adult cattle vaccination using strain 19 in selected dairy herds in Florida. Proceedings of the annual meeting of the United States Animal Health Association 80, 91–100 (1976).
   Google Scholar
• Al-Khalaf SA, Mohamad BT, Nicoletti P. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with Brucella abortus strain 19 or Brucella melitensis strain Rev.1. Trop. Anim. Health Prod. 24, 45–49 (1992).
   PubMedGoogle Scholar
• Nicoletti P. The effects of adult cattle vaccination with strain 19 on the incidence of brucellosis in dairy herds in Florida and Puerto Rico. Proceedings of the United States Animal Health Association 83, 75–80 (1979).
   Google Scholar
• Corner LA, Alton GG. Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses. Res. Vet. Sci. 31, 342–344 (1981).
   PubMed Web of Science ®Google Scholar
• Moore T, Mitchell CA. Vaccination of sexually mature cows with Brucella abortus strain 19 vaccine. Can. J. Comp. Med. 14, 209–213 (1950).
   PubMedGoogle Scholar
• Schurig GG, Roop RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28, 171–188 (1991).
   PubMed Web of Science ®Google Scholar
• Cloeckaert A, Zygmunt MS, Guilloteau LA. Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen. Vaccine 20, 1820–1822 (2002).
   PubMedGoogle Scholar
• Olsen SC, Bricker B, Palmer MV, Jensen AE, Cheville NF. Responses of cattle to two dosages of Brucella abortus strain RB51: Serology, clearance and efficacy. Res. Vet. Sci. 66, 101–105 (1999).
   PubMedGoogle Scholar
• Olsen SC. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle. Vet. Therapeutics 1, 183–191 (2000).
   Google Scholar
• Olsen SC, Evans D, Hennager SG, Cheville NF, Stevens MG. Serologic responses of calfhood-vaccinated cattle to Brucella abortus strain RB51. J. Vet. Diagnostic Invest. 8, 451–454 (1996).
   PubMedGoogle Scholar
• Uzal FA, Samartino L, Schurig G et al. Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle. Vet. Res. Comm. 24, 143–151 (2000).
   PubMedGoogle Scholar
• Leal-Hernandez M, Díaz-Aparicio E, Pérez R. Protection of Brucella abortus RB51 revaccinated cows, introduced in a herd with active brucellosis, with presence of atypical humoral response. Comp. Immunol. Microbiol. Infect. Dis. 28, 63–70 (2005).
   PubMedGoogle Scholar
• Cheville NF, Olsen SC, Jensen AE, Stevens MG, Palmer MV, Forance AM. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am. J. Vet. Res. 57, 1153–1156 (1996).
   PubMed Web of Science ®Google Scholar
• Palmer MV, Olsen SC, Cheville NF. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am. J. Vet. Res. 58, 472–477 (1997).
   PubMedGoogle Scholar
• Olsen SC. Responses of adult cattle to vaccination with a reduced dose of Brucella abortus strain RB51. Res. Vet. Sci. 69, 135–140 (2000).
   PubMedGoogle Scholar
• Palmer MV, Cheville NF, Jensen AE. Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic and serologic findings. Vet. Pathol. 33, 682–691 (1996).
   PubMedGoogle Scholar
• Van Metre DC, Kennedy GA, Olsen SC, Hansen GR, Ewalt DR. Brucellosis induced by RB51 vaccine in a pregnant heifer. J. Am. Vet. Med. Assoc. 215, 1491–1493 (1999).
   PubMedGoogle Scholar
• Samartino LE, Fort M, Gregoret R, Schurig GG. Use of Brucella abortus vaccine strain RB51 in pregnant cows after calfhood vaccination with strain 19 in Argentina. Prev. Vet. Med. 45, 193–199 (2000).
   PubMedGoogle Scholar
• Lord VR, Schurig GG, Cherwonogrodzky JW, Marcano MJ, Melendez GE. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am. J. Vet. Res. 59, 1016–1020 (1998).
   PubMed Web of Science ®Google Scholar
• Ashford DA, Di Pietra J, Lingappa JJ et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine 22, 3435–3439 (2004).
   PubMed Web of Science ®Google Scholar
• Adone R, Ciuchini F. Complement fixation test to assess humoral immunity in cattle and sheep vaccinated with Brucella abortus RB51. Clin. Diag. Lab. Immunol. 6, 787–790 (1999).
   PubMedGoogle Scholar
• Cheville NF, Jensen AE, Halling SM et al. Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus. Am. J. Vet. Res. 53, 1881–1888 (1992).
   PubMedGoogle Scholar
• Cheville NF, Stevens MG, Jensen AE, Tatum FM, Halling SM. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of of Brucella abortus. Am. J. Vet. Res. 53, 1881–1888 (1992).
   PubMedGoogle Scholar
• Alton GG. Brucella melitensis. In: Animal Brucellosis. K Nielsen, JR Duncan (Eds.) CRC Press, Boston, MA. 385–409 (1990).
   Google Scholar
• Refai M. Incidence and control of brucellosis in the Near East region. Vet. Microbiol. 90, 81–110 (2002).
   PubMedGoogle Scholar
• Renukaradhya GJ, Isloor S, Rajasekhar M. Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet. Microbiol. 90, 183–195 (2002).
   PubMed Web of Science ®Google Scholar
• Alton GG. Brucella melitensis infection in female kids born into a heavily infected environment. Br. Vet. J. 126, 61–67 (1970).
   PubMedGoogle Scholar
• Herzberg M, Elberg SS. Immunization against Brucella infection. I. Isolation and characterization of a streptomycin-dependent mutant. J. Bacteriol. 66, 585–599 (1953).
   PubMed Web of Science ®Google Scholar
• Alton GG, Elberg SS. Rev.1 Brucella melitensis vaccine. Vet. Bull. 37, 793–800 (1967).
   Google Scholar
• Elzer PH. Enright FM, McQuiston JR, Boyle SM, Schurig GG. Evaluation of a rough mutant of Brucella melitensis in pregnant goats. Res. Vet. Sci. 64, 259–260 (1998).
   PubMedGoogle Scholar
• El Idrissi AH, Benkirane A, El Maadoudi M, Bouslikhanne M, Berrada J, Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev. Sci. Tech. Off. Int. Epiz 20, 741–747 (2001).
   PubMedGoogle Scholar
• Blasco JM. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev. Vet. Med. 31, 275–283 (1997).
   PubMed Web of Science ®Google Scholar
• Elberg SS. Rev 1 Brucella melitensis vaccine. Part II 1968–1980. Vet. Bull. 51, 67–73 (1981).
   Google Scholar
• Fensterbank R, Pardon P, Marly J. Comparison between subcutaneous and conjunctival route of vaccination with Rev 1 strain against Brucella melitensis in ewes. Ann. Rech. Vet. 13, 295–301 (1982).
   PubMedGoogle Scholar
• Blasco M., Estrada A Mercadal M. A note on adult sheep vaccination with reduced dose of Brucella melitensis Rev 1. Ann. Rech Vet. 15, 553–556 (1984).
   PubMedGoogle Scholar
• Díaz-Aparicio E, Hernández L, Suárez-Güemes F. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine. Trop. Anim. Health Prod. 36, 117–121 (2004).
   PubMedGoogle Scholar
• Jiménez de Bagués MP, Marín CM, Barberán M, Blasco JM. Responses of ewes to B. melitensis Rev 1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy. Ann. Rech. Vet. 20, 205–213 (1989).
   PubMedGoogle Scholar
• Zundel E, Verger JM, Grayon M, Michel R. Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: safety and serologic responses. Ann. Rech. Vet. 23, 177–188 (1992).
   PubMedGoogle Scholar
• Booseray N. Brucella melitensis Rev 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice. Biologicals 19, 355–363 (1991).
   Google Scholar
• Marín CM, Moreno E, Moriyón I, Díaz R, Balsco JM. Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis. Clin. Diagn. Lab. Immunol. 6, 269–272 (1999).
   PubMedGoogle Scholar
• Entessar F, Ardalan A, Ebadi A, Jones LM. Effect of living Rev.1 vaccine in producing long-term immunity against Brucella melitensis infection in sheep in Iran. J. Comp. Path. 77, 367–376 (1967).
   PubMedGoogle Scholar
• Bardenstein S, Mandelboim M, Ficht TA, Baum M, Banai M. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J. Clin. Microbiol. 40, 1475–1480 (2002).
   PubMedGoogle Scholar
• Moreno E. Brucellosis in Central America. Vet. Microbiol. 90, 31–38 (2002).
   PubMedGoogle Scholar
• Dequi S, Donglou X, Jiming Y. Epidemiology and control of brucellosis in China. Vet. Microbiol. 90, 165–182 (2002).
   PubMedGoogle Scholar
• Vargas O FJ. Brucellosis in Venezuela. Vet. Microbiol. 90, 39–44 (2002).
   PubMedGoogle Scholar
• Samartino LE. Brucellosis in Argentina. Vet. Microbiol. 90, 71–80 (2002).
   PubMed Web of Science ®Google Scholar
• McDermott JJ, Arimi SM. Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet. Microbiol. 90, 111–134 (2002).
   PubMed Web of Science ®Google Scholar
• Godfroid J, Käsbohrer A. Brucellosis in the European Union and Norway at the turn of the twenty–first century. Vet. Microbiol. 90, 135–145 (2002).
   PubMed Web of Science ®Google Scholar
• Becker HN, Belden RC, Breault T, Burridge MJ, Frankenberger WB, Nicoletti P. Brucellosis in feral swine in Florida. J. Am. Vet. Med. Assoc. 173, 1181–1182 (1978).
   PubMedGoogle Scholar
• Mason RJ, Fleming PJS. Serological survey for Brucella antibodies in feral pigs from eastern Australia. Aust. Vet. J. 77, 331–332 (1999).
   PubMedGoogle Scholar
• Trout, D, Gomez TM, Bernard BP et al. Outbreak of brucellosis at a United States pork packing plant. J. Occupational Environ. Med. 37, 697–703 (1995).
   PubMedGoogle Scholar
• Lord VR, Cherwonogrodzky JW, Schurig GG, Lord RD, Marcano MJ, Melendez GE. Venezuelan field trials of vaccines against brucellosis in swine Am. J. Vet. Res. 59, 546–551 (1998).
   PubMedGoogle Scholar
• Edmonds MD, Samartino LE, Hoyt PG et al. Oral vaccination of sexually mature pigs with Brucella abortus strain RB51. Am. J. Vet. Res. 62, 1328–1331 (2001).
   PubMedGoogle Scholar
• Blasco JM. Brucella ovis. In: Animal Brucellosis. K Nielsen JR Duncan (Eds) CRC Press, Boston, MA. pp 351–378 (1990).
   Google Scholar
• Marco J, González L, Cuervo LA et al. Brucella ovis infection in two flocks of sheep. Vet. Rec. 135, 254–256 (1994).
   PubMedGoogle Scholar
• Reichel MP, Baber DJ, Armitage PW, Lampard D, Whitley RS, Hilbink F. Eradication of Brucella ovis from the Falkland Islands 1977–1993. Vet. Rec. 134, 595–597 (1994).
   PubMed Web of Science ®Google Scholar
• Arsenault J, Girard C, Dubreuil P., Bélanger D. Lack of evidence of Brucella ovis infection in rams in Quebec. Can. Vet. J. 45, 312–313 (2004).
   PubMedGoogle Scholar
• Marín CM, Barberán M, Jiménez de Bagüés MP, Blasco JM. Comparison of subcutaneous and conjunctival routes of Rev.1 vaccination for the prophylaxis of Brucella ovis infection in rams. Res. Vet. Sci. 48, 209–215 (1990).
   PubMedGoogle Scholar
• Claxton P.D. Brucella ovis vaccination of rams. A comparison of two commercial vaccines and two methods of vaccination. Aust. Vet. J. 44, 48–54 (1968).
   PubMed Web of Science ®Google Scholar
• McGowan B, Harrold DR. Epididymitis in rams: studies on vaccine efficacy. Cornell Vet. 69, 73–76 (1979).
   PubMedGoogle Scholar
• Jiménez de Bagüés MP, Barberán, Marín CM, Blasco JM. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine 13, 301–304 (1995).
   PubMedGoogle Scholar
• Blasco JM, Marín CM, Jiménez de Bagüés MP, Barberán M. Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams. Vaccine 11, 1291–1294 (1993).
   PubMedGoogle Scholar
• Mousa ARM. El Hag KM, Khogali M, Marafie AA. The nature of human brucellosis in Kuwait: study of 379 cases. Rev Infect Dis 10, 211–217 (1989).
   Google Scholar
• Abbas B, Agab H. A review of camel brucellosis. Prev. Vet. Med. 55, 47–56 (2002).
   PubMed Web of Science ®Google Scholar
• Ferguson MA. Rangiferine brucellosis on Baffin Island. J. Wildlife Dis. 33, 536–543 (1997).
   PubMed Web of Science ®Google Scholar
• Waghela S, Karstad L. Antibodies to Brucella spp. Among blue wildebeest and African buffalo in Kenya. J. Wildlife Dis. l22, 189–192 (1986).
   Google Scholar
• Herr S, Marshall C. Brucellosis in free-living African buffalo (Syncerus caffer): a serological survey. Onderstepoort J. Vett. Res. 48, 133–134 (1981).
   PubMed Web of Science ®Google Scholar
• Hillman B. Brucellosis in Eastern Idaho. Proc. USA Health Assoc. 106, 189–192 (2002)
   Google Scholar
• Roffe TJ, Olsen SC, Gidlewski T, Jensen AE, Palmer MV, Huber R. Biosafety of parenteral Brucella abortus RB51 vaccine in bison calves. J. Wildlife Management 63, 950–955 (1999).
   Google Scholar
• Olsen SC, Kreeger TJ, Palmer MV. Immune responses of elk to vaccination with Brucella abortus strain RB51. J Wildlife Dis. 38, 756–751 (2002).
   Google Scholar
• Thorne ET, Walthall TJ, Dawson HA. Vaccination of elk with strain 19 Brucella abortus. Proceedings of the United States Animal Health Association 85, 359–374 (1981).
   Google Scholar
• Herriges JD, Thorne ET, Anderson SL, Dawson HA. Vaccination of elk in Wyoming with reduced dose strain 19 Brucella: Controlled studies and ballistic implant field trials. Proceedings of the United States Animal Health Association 93, 640–655 (1989).
   Google Scholar
• Kreeger T J, Cook WE, Edwards WH, Elzer PH, Olsen SC. Brucella abortus strain RB51 vaccination in elk II. Failure of high dosage to prevent abortion. J. Wildlife Dis. 38, 27–31 (2002).
   PubMedGoogle Scholar
• Olsen SC, Jensen AE, Stoffregen WC, Palmer MV. Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis. Res. Vet. Sci. 74, 17–22 (2003).
   PubMedGoogle Scholar
• Diptee MD, Adesiyun AA, Asgarali Z, Campbell M, Fosgate GT. Evaluation of cell-mediated immune responses and bacterial clearance in 6–10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine. Vet. Immunol. Immunopath. 106, 209–220 (2005).
   PubMedGoogle Scholar
• Fosgate GT, Adesiyun AA, Hird DW et al. Evaluation of brucellosis RB51 vaccine for domestic water buffalo (Bubalus bubalis) in Trinidad. Prev. Vet. Med. 58, 211–225 (2003).
   PubMedGoogle Scholar
• Radwan AJ, Bekairi SI, Mukayel AA et al. Control of Brucella melitensis infection in a large camel herd in Saudi Arabia using antibiotherapy and vaccination with Rev.1 vaccine. Rev. Sci. Tech. Off. Int. Epiz. 14, 719–732 (1995).
   PubMed Web of Science ®Google Scholar
• Olsen SC, Kreeger TJ, Schultz W. Immune responses of bison to ballistic or hand vaccination with Brucella abortus strain RB51. J. Wildlife Dis. 38, 738–745 (2002).
   PubMedGoogle Scholar